|
|||||
KaletraActive Ingredient(s): Lopinavir + RitonavirFirst Approved by the FDA: September 15, 2000 Pharmaceutical Company: ABBOTT Kaletra Article SummaryLopinavir (abt-378) Is An Antiretroviral Of The Protease Inhibitor Class. It Is Marketed By Abbott As Kaletra (capsules) And Aluvia (non-refrigerated Tablets), Both Of Which Represent A Co-formulation With A Sub-therapeutic Dose Of Ritonavir, As A Component Of Combination Therapy To Treat Hiv/aids. The Kaletra Formulation Has Also Been Used Successfully As Monotherapy In Some Studies.[1] as Of 2006, Lopinavir/ritonavir Forms Part Of The Preferred Combination For First-line Therapy Recommended By ... Read the Full Kaletra ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Kaletra Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to KaletraCapsule 133.3mg + 33.3mg Solution 80mg/ml + 20mg/ml Tablet 100mg + 25mg, 200mg + 50mg Related Drug Page(s):Other Drugs Containing Lopinavir or Ritonavir or a Similar Compund: Related Search Results for KaletraWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Kaletra Text Link HTML Code: Related: substance document review list medicine Kaletra, report Kaletra, Kaletra technical approval contraindications schedule, Kaletra instructions discussions, Kaletra national description, posting alert addiction Kaletra, class digest Kaletra, alternative Kaletra, Kaletra report list imprint, Kaletra efficacy identify pertinent institute. pharmacy side effects discussions approval Lopinavir + Ritonavir, Lopinavir + Ritonavir consultation contraindications rx instructions, online interactions discussions research symptoms Lopinavir + Ritonavir, Lopinavir + Ritonavir FDA what is about international, identification Lopinavir + Ritonavir, policy history trials studies history Lopinavir + Ritonavir. Return to Top  Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Kaletra.asp Last Updated June 27 2005 |
|||||
Home Page
